- Home
- OGI
as 02-21-2025 4:00pm EST
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
| Founded: | 2013 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 170.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.24 - $2.91 | Next Earning Date: | 02-11-2025 |
| Revenue: | $115,451,336 | Revenue Growth: | -0.18% |
| Revenue Growth (this year): | 50.11% | Revenue Growth (next year): | 16.16% |
Latest Organigram Holdings Inc. News
OGI Breaking Stock News: Dive into OGI Ticker-Specific Updates for Smart Investing
Insider Monkey
4 days ago
Organigram Holdings Inc. (OGI): A Bull Case Theory
GuruFocus.com
10 days ago
OrganiGram Holdings Inc (OGI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Motley Fool
11 days ago
Organigram (OGI) Q1 2025 Earnings Call Transcript
Zacks
11 days ago
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
Associated Press Finance
11 days ago
OrganiGram: Fiscal Q1 Earnings Snapshot
MT Newswires
11 days ago
OrganiGram Down 6.4% in Pre-market Trading as Q1 Loss Widens and Revenue Misses Forecasts
Business Wire
11 days ago
Organigram Reports First Quarter Fiscal 2025 Results
Business Wire
18 days ago
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
Compare OGI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OGI Organigram Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.